Literature DB >> 19730399

Atopy and upper and lower airway disease among former World Trade Center workers and volunteers.

Rafael E de la Hoz1, Michael R Shohet, Juan P Wisnivesky, Laura A Bienenfeld, Aboaba A Afilaka, Robin Herbert.   

Abstract

OBJECTIVE: A large number of workers seemed to have developed upper and lower airway disease (UAD and LAD, respectively) in relation to their occupational exposures at the World Trade Center (WTC) disaster site. This study examined atopy as a risk factor for presumably WTC-related UAD and LAD.
METHODS: Atopy was examined in 136 former WTC workers and volunteers by radioallergosorbent test, skin prick testing, or both. Overall prevalence of atopy was estimated, and bivariate and multivariate logistic regression analyses were conducted to examine associations of atopy with WTC-related UAD and LAD.
RESULTS: Atopy was prevalent in 54.4% of these WTC workers. Atopy was associated with higher symptom severity scores for both WTC-related UAD and LAD. Atopy was a predictor of WTC-related UAD but not LAD. Early arrival at the WTC site, and pre-2001 asthma diagnosis were predictors of LAD.
CONCLUSION: The prevalence of atopy in this population is similar to what has been described for the general U.S. population. Atopy seemed to be a risk factor for presumably WTC-related UAD but not for LAD.

Entities:  

Mesh:

Year:  2009        PMID: 19730399     DOI: 10.1097/JOM.0b013e3181b32093

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  8 in total

1.  Roles of MAPK pathway activation during cytokine induction in BEAS-2B cells exposed to fine World Trade Center (WTC) dust.

Authors:  Shang Wang; Colette Prophete; Joleen M Soukup; Lung-Chi Chen; Max Costa; Andrew Ghio; Qingshan Qu; Mitchell D Cohen; Haobin Chen
Journal:  J Immunotoxicol       Date:  2010-08-24       Impact factor: 3.000

2.  Occupational rhinosinusitis and upper airway disease: the world trade center experience.

Authors:  Rafael E de la Hoz; Michael R Shohet; Jeffrey M Cohen
Journal:  Curr Allergy Asthma Rep       Date:  2010-03       Impact factor: 4.806

3.  Mental health, long-term medication adherence, and the control of asthma symptoms among persons exposed to the WTC 9/11 disaster.

Authors:  Jennifer Brite; Stephen Friedman; Rafael E de la Hoz; Joan Reibman; James Cone
Journal:  J Asthma       Date:  2019-10-10       Impact factor: 2.515

4.  Increased Airway Wall Thickness is Associated with Adverse Longitudinal First-Second Forced Expiratory Volume Trajectories of Former World Trade Center workers.

Authors:  Rafael E de la Hoz; Xiaoyu Liu; John T Doucette; Anthony P Reeves; Laura A Bienenfeld; Juan P Wisnivesky; Juan C Celedón; David A Lynch; Raúl San José Estépar
Journal:  Lung       Date:  2018-05-24       Impact factor: 2.584

5.  Gene-environment interactions influence airways function in laboratory animal workers.

Authors:  Karin A Pacheco; Cecile S Rose; Lori J Silveira; Michael V Van Dyke; Kelly Goelz; Kristyn MacPhail; Lisa A Maier
Journal:  J Allergy Clin Immunol       Date:  2010-06-25       Impact factor: 10.793

6.  Occupational asthma and lower airway disease among World Trade Center workers and volunteers.

Authors:  Rafael E de la Hoz
Journal:  Curr Allergy Asthma Rep       Date:  2010-07       Impact factor: 4.806

7.  Increased pulmonary artery diameter is associated with reduced FEV1 in former World Trade Center workers.

Authors:  Rafael E de la Hoz; Yunho Jeon; Anthony P Reeves; Raúl San José Estépar; Xiaoyu Liu; John T Doucette; Juan C Celedón; Anna Nolan
Journal:  Clin Respir J       Date:  2019-08-19       Impact factor: 2.570

8.  The upper respiratory pyramid: early factors and later treatment utilization in World Trade Center exposed firefighters.

Authors:  Justin K Niles; Mayris P Webber; Xiaoxue Liu; Rachel Zeig-Owens; Charles B Hall; Hillel W Cohen; Michelle S Glaser; Jessica Weakley; Theresa M Schwartz; Michael D Weiden; Anna Nolan; Thomas K Aldrich; Lara Glass; Kerry J Kelly; David J Prezant
Journal:  Am J Ind Med       Date:  2014-06-04       Impact factor: 2.214

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.